Steven Feldman to Health Expenditures
This is a "connection" page, showing publications Steven Feldman has written about Health Expenditures.
Connection Strength
3.647
-
Payne JE, Ghamrawi RI, Lin IJ, Feldman SR. Utilization of an Online Cash-Pay Pharmacy for Topical 5-Fluorouracil Prescriptions in Older Patients. J Drugs Dermatol. 2020 May 01; 19(5):539-542.
Score: 0.679
-
Feldman SR, Pelletier CL, Wilson KL, Mehta RK, Brouillette MA, Smith D, Bonafede MM. Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis. J Comp Eff Res. 2019 07; 8(9):699-709.
Score: 0.635
-
Turbeville JG, Alinia H, Tuchayi SM, Bahrami N, Cardwell LA, Awosika O, Richardson I, Huang KE, Feldman SR. Patient Costs Associated with Rosacea. Dermatol Clin. 2018 Apr; 36(2):167-170.
Score: 0.577
-
Al Sawah S, Foster SA, Goldblum OM, Malatestinic WN, Zhu B, Shi N, Song X, Feldman SR. Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis. J Med Econ. 2017 Sep; 20(9):982-990.
Score: 0.559
-
Yentzer BA, Gustafson CJ, Feldman SR. Explicit and implicit copayments for phototherapy: examining the cost of commuting. Dermatol Online J. 2013 Jun 15; 19(6):18563.
Score: 0.422
-
Parks L, Balkrishnan R, Hamel-Gariépy L, Feldman SR. The importance of skin disease as assessed by "willingness-to-pay". J Cutan Med Surg. 2003 Sep-Oct; 7(5):369-71.
Score: 0.215
-
Bashyam AM, Williford PM, Feldman SR. Safe Step Act: does it undermine step therapy? Dermatol Online J. 2020 Apr 15; 26(4).
Score: 0.169
-
Feldman SR, Wu JJ, Rastogi S, Menges B, Lingohr-Smith M, Lin J. The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans. J Med Econ. 2018 May; 21(5):537-541.
Score: 0.145
-
Dothard EH, Sandoval LF, Yentzer BA, Feldman SR. Home ultraviolet light therapy for psoriasis: why patients choose other options. Dermatol Online J. 2014 Dec 13; 21(2).
Score: 0.117
-
Wu EQ, Feldman SR, Chen L, Kaltenboeck A, Yu AP, Gupta SR, Laitinen D, Willian MK. Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population. Curr Med Res Opin. 2008 Dec; 24(12):3493-501.
Score: 0.077
-
Housman TS, Feldman SR, Williford PM, Fleischer AB, Goldman ND, Acostamadiedo JM, Chen GJ. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003 Mar; 48(3):425-9.
Score: 0.052